Free Trial

Anebulo Pharmaceuticals (ANEB) Institutional Ownership

Anebulo Pharmaceuticals logo
$0.46 -0.06 (-11.54%)
As of 05/14/2026 01:41 PM Eastern

Institutional Ownership Changes (13F Filings) for Anebulo Pharmaceuticals (NASDAQ:ANEB)

Current
Institutional Ownership
Percentage
28.40%
Number of
Institutional Buyers
(last 12 months)
1
Total
Institutional Inflows
(last 12 months)
$124.68K
Number of
Institutional Sellers
(last 12 months)
0
Get ANEB Insider Trade Alerts

Want to know when executives and insiders are buying or selling Anebulo Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Chart & View Institutional Buying and Selling Data

ANEB Institutional Buying and Selling by Quarter

Anebulo Pharmaceuticals Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
6/27/2025Goldman Sachs Group Inc.47,954$62K0.0%N/A0.117%
5/16/2025Goldman Sachs Group Inc.47,954$62K0.0%N/A0.117%
4/9/2025LVW Advisors LLC349,617$455K0.1%-44.7%0.851%
2/17/202522NW LP15,467,300$25.99M18.5%+188.2%59.650%
2/14/2025Nantahala Capital Management LLC3,036,325$5.10M0.2%+494.1%11.710%
2/7/2025King Luther Capital Management Corp59,662$100K0.0%N/A0.230%
1/16/2025LVW Advisors LLC632,516$1.06M0.1%-1.3%2.439%
1/16/2024LVW Advisors LLC643,039$1.56M0.3%-4.4%2.509%
2/8/2023Herr Investment Group LLC29,644$72K0.0%N/A0.116%
11/10/2022Nantahala Capital Management LLC511,073$1.43M0.1%N/A1.994%
10/14/2022LVW Advisors LLC674,964$1.89M0.4%-3.6%2.888%
7/22/2022LVW Advisors LLC700,000$3.64M0.7%N/A2.999%


ANEB Institutional Ownership - Frequently Asked Questions

During the previous two years, the following institutional investors and hedge funds held shares of Anebulo Pharmaceuticals shares: 22NW LP ($25.99M), Nantahala Capital Management LLC ($5.10M), LVW Advisors LLC ($455K), and King Luther Capital Management Corp ($100K), Goldman Sachs Group Inc. ($62K).Learn more on Anebulo Pharmaceuticals' institutional investors.

28.40% of Anebulo Pharmaceuticals' stock is owned by institutional investors. Learn more on ANEB's institutional investor holdings.

The following institutional investors have purchased Anebulo Pharmaceuticals' stock in the last 24 months: 22NW LP ($10.10M), Nantahala Capital Management LLC ($2.53M), Goldman Sachs Group Inc. ($95.91K), and King Luther Capital Management Corp ($59.66K).

Institutional investors have bought a total of 95,908 shares in the last 24 months. This purchase volume represents approximately $124.68K in transactions.



This page (NASDAQ:ANEB) was last updated on 5/15/2026 by MarketBeat.com Staff.
From Our Partners